Skip to main content
main-content

01.12.2012 | Research | Ausgabe 1/2012 Open Access

Health and Quality of Life Outcomes 1/2012

Distance saturation product predicts health–related quality of life among sarcoidosis patients

Zeitschrift:
Health and Quality of Life Outcomes > Ausgabe 1/2012
Autoren:
Julie M Bourbonnais, Subramanian Malaisamy, Bhavinkumar D Dalal, Priyan C Samarakoon, Swapna R Parikh, Lobelia Samavati
Wichtige Hinweise

Competing interests

No conflicts of interest were identified by any of the authors. No sources provided support in the form of grants, gifts, equipment, and/or drugs to any of the authors involved in this publication.

Authors’ contributions

JMB participated in design of the study and drafted the manuscript. SM participated in data collection and in drafting the manuscript. BDD performed statistical analysis. PCS and SRP participated in design of the study and data collection. LS conceived of the study, participated in its design and coordination, performed statistical analysis and helped draft the manuscript.

Abstract

Background

Sarcoidosis is a chronic disease with different phenotypic manifestations. Health-related quality of life is an important aspect in sarcoidosis, yet difficult to measure. The objective of this study was to identify clinical markers predictive of poor quality of life in sarcoidosis patients that can be followed over time and targeted for intervention.

Methods

We assessed the quality of life of 162 patients with confirmed sarcoidosis in a prospective, cross-sectional study using the Sarcoidosis Health Questionnaire (SHQ) and Short Form-36 Health Survey (SF-36). We evaluated the validity of these questionnaires and sought to identify variables that would best explain the performance scores of the patients.

Results

On multivariate regression analyses, the very best composite model to predict total scores from both surveys was a model containing the distance-saturation product and Borg Dyspnea Scale score at the end of a 6-min walk test. This model could better predict SF-36 scores (R2 = 0.33) than SHQ scores (R2 = 0.24). Substitution of distanced walked in 6 min for the distance-saturation product in this model resulted in a lesser ability to predict both scores (R2 = 0.26 for SF-36; R2 = 0.22 for SHQ).

Conclusions

Both the SHQ and SF-36 surveys are valuable tools in the assessment of health-related quality of life in sarcoidosis patients. The best model to predict quality of life among these patients, as determined by regression analyses, included the distance-saturation product and Borg score after the 6-min walk test. Both variables represent easily obtainable clinical parameters that can be followed over time and targeted for intervention.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Health and Quality of Life Outcomes 1/2012 Zur Ausgabe